Electra Therapeutics, Inc. ETRA
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
--
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | -- | -- | -- | ||
| Cost of Revenue | -- | -- | -- | ||
| Gross Profit | -- | -- | -- | ||
| SG&A Expenses | 4.30M | 4.30M | 3.29M | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 25.12M | 25.12M | 12.68M | ||
| Operating Income | -25.12M | -25.12M | -12.68M | ||
| Income Before Tax | -24.46M | -24.46M | -12.68M | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | -24.46M | -24.46M | -12.68M | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -24.46M | -24.46M | -12.68M | ||
| EBIT | -25.12M | -25.12M | -12.68M | ||
| EBITDA | -25.05M | -25.05M | -- | ||
| EPS Basic | -665.76 | -665.76 | -288.19 | ||
| Normalized Basic EPS | -347.39 | -347.39 | -180.12 | ||
| EPS Diluted | -665.76 | -665.76 | -288.19 | ||
| Normalized Diluted EPS | -347.39 | -347.39 | -180.12 | ||
| Average Basic Shares Outstanding | 44.00K | 44.00K | 44.00K | ||
| Average Diluted Shares Outstanding | 44.00K | 44.00K | 44.00K | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||